<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T10:25:30Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7444" metadataPrefix="marc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7444</identifier><datestamp>2026-02-06T12:53:36Z</datestamp><setSpec>com_10259_4363</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_3924</setSpec><setSpec>com_10259.4_2516</setSpec><setSpec>com_10259_3592</setSpec><setSpec>com_10259_3591</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_4364</setSpec><setSpec>col_10259_3925</setSpec><setSpec>col_10259.4_2517</setSpec><setSpec>col_10259_3930</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Echevarría Poza, Igor</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Zafon, Elisenda</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Barrabés, Sílvia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Martínez, María Ángeles</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Ramos Gómez, Sonia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Ortega Santamaría, Natividad</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Manzano, Blanca R.</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Jalón Sotés, Félix Ángel</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Quesada Pato, Roberto</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Espino Ordóñez, Gustavo</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Massaguer Vall-Llovera, Anna</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2022-06</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Despite their outstanding properties as potential photosensitizers for photodynamic therapy (PDT), Ir(III) biscyclometalated complexes need both further developments to overcome remaining limitations and in-depth&#xd;
investigations into their mechanisms of action to reach clinic application in the treatment of cancer. This&#xd;
work describes the synthesis of a family of Ir(III) complexes of general formula [Ir(C^N)2(N^N′&#xd;
)]Cl (N^N′ =&#xd;
thiabendazole-based ligands; C^N = ppy (2-phenylpyridinate) (Series A), or dfppy (2-(2,4-difluorophenyl)pyridinate) (Series B)) and their evaluation as potential PDT agents. These complexes are partially soluble in water&#xd;
and exhibit cytotoxic activity in the absence of light irradiation versus several cancer cell lines. Furthermore, the&#xd;
cytotoxic activity of derivatives of Series A is enhanced upon irradiation, particularly for complexes [1a]Cl and&#xd;
[3a]Cl, which show phototoxicity indexes (PI) above 20. Endocytosis was established as the uptake mechanism&#xd;
for [1a]Cl and [3a]Cl in prostate cancer cells by flow cytometry. These derivatives mainly accumulate in the&#xd;
mitochondria as shown by colocalization confocal microscopy experiments. Presumably, [1a]Cl and [3a]Cl&#xd;
induce death on cancer cells under irradiation through apoptosis triggered by a multimodal mechanism of action,&#xd;
which likely involves damage over mitochondrial DNA and mitochondrial membrane depolarization. Both&#xd;
processes seem to be the result of photocatalytic oxidation processes.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">0162-0134</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">http://hdl.handle.net/10259/7444</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.1016/j.jinorgbio.2022.111790</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Photodynamic therapy</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Iridium</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Cyclometalated complexes</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Cancer</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Mitochondria</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">DNA</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>